Lucira Health, Inc. Common Stock
LHDX
LHDX was delisted on the 3rd of March, 2023.
36 hedge funds and large institutions have $132M invested in Lucira Health, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 18 closing their positions.
367% more call options, than puts
Call options by funds: $947K | Put options by funds: $203K
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
22% more capital invested
Capital invested by funds: $108M → $132M (+$23.9M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less funds holding
Funds holding: 44 → 36 (-8)
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$5.08M |
| 2 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$4.88M |
| 3 |
ECG
EPIQ Capital Group
San Francisco,
California
|
+$4.24M |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$1.86M |
| 5 |
Millennium Management
New York
|
+$1.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JCM
JS Capital Management
New York
|
-$2.66M |
| 2 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$2.13M |
| 3 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$558K |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$401K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$242K |
LHDX Hedge Fund Activity: Q3 2021 in Review
36 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Lucira Health, Inc. Common Stock (LHDX) for Q3 2021, worth a combined $132M — up 22% from $108M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of LHDX and 10 opened new positions — a net loss of 8 holders — while 8 trimmed existing stakes and 13 added.
The largest buyer was Pura Vida Investments, adding an estimated $5.08M. The largest seller was JS Capital Management, exiting entirely with an estimated $2.66M sold.
- 36 institutional investors held Lucira Health, Inc. Common Stock (LHDX) as of Q3 2021, down from 44 in Q2 2021.
- Funds reported $132M of Lucira Health, Inc. Common Stock stock for Q3 2021, up 22% quarter-over-quarter.
- 10 funds opened new Lucira Health, Inc. Common Stock positions in Q3 2021 and 18 closed out, a net change of -8 holders.
- The largest Lucira Health, Inc. Common Stock buyer in Q3 2021 was Pura Vida Investments, an estimated $5.08M added.
- The largest Lucira Health, Inc. Common Stock seller in Q3 2021 was JS Capital Management, an estimated $2.66M sold.
Based on aggregated 13F filings for Q3 2021.